Yes, 7.5 mg mirtazapine is stronger than 3.75 mg
A 7.5 mg dose of mirtazapine produces greater pharmacological effects than a 3.75 mg dose, as evidenced by dose-dependent increases in drug exposure and clinical effects. This is a straightforward dose-response relationship where higher doses deliver more medication to the body.
Pharmacokinetic Evidence
The FDA-approved starting dose of mirtazapine is 15 mg daily, with 7.5 mg representing a half-dose that is sometimes used in clinical practice 1. While 3.75 mg is below standard dosing ranges, research demonstrates clear dose-dependent pharmacokinetics:
- In healthy volunteers, mirtazapine 7.5 mg produced less subjective somnolence and fewer driving impairments compared to 15 mg, indicating dose-dependent central nervous system effects 2
- In cats (which metabolize mirtazapine similarly to humans), the 3.75 mg dose showed significantly different pharmacokinetic parameters compared to the 1.88 mg dose, with higher AUC and drug exposure at the higher dose 3
Clinical Dosing Context
The standard therapeutic range for mirtazapine is 15-45 mg daily 1. Multiple guidelines consistently recommend:
- Starting dose: 7.5-15 mg at bedtime for insomnia and depression 4, 5, 6
- Maximum dose: 30-45 mg daily for full antidepressant effects 4, 7, 1
The 7.5 mg dose sits at the lower end of the therapeutic spectrum and is primarily used when:
- Sedation is the primary goal (insomnia, palliative care)
- Patients are elderly or medically frail
- Minimizing side effects is critical
Important Caveats
Mirtazapine exhibits paradoxical pharmacology: At lower doses (7.5-15 mg), it is more sedating due to predominant antihistamine effects, while at higher doses (30-45 mg), increased noradrenergic activity can offset sedation 4, 5. This means that while 7.5 mg delivers more drug than 3.75 mg, the clinical effect profile changes with dose escalation beyond 15 mg.
The 3.75 mg dose is sub-therapeutic and not supported by any guideline or FDA labeling 1. This dose would be considered off-label and likely insufficient for any standard indication.